Rockefeller Financial Services’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.02M	Hold	8,550	–	–	0.02%	227
2017 Q3	$1.2M	Hold	8,550	–	–	0.02%	190
2017 Q2	$1.04M	Sell	8,550 -707	-8%	-$82.3K	0.02%	184
2017 Q1	$1.12M	Hold	9,257	–	–	0.02%	180
2016 Q4	$1.13M	Hold	9,257	–	–	0.02%	185
2016 Q3	$1.13M	Hold	9,257	–	–	0.02%	180
2016 Q2	$1.08M	Hold	9,257	–	–	0.02%	195
2016 Q1	$1.29M	Sell	9,257 -2,888	-24%	-$424K	0.03%	175
2015 Q4	$2.32M	Sell	12,145 -3,081	-20%	-$538K	0.05%	147
2015 Q3	$2.38M	Sell	15,226 -230,327	-94%	-$42M	0.05%	142
2015 Q2	$44.4M	Buy	245,553 +48,546	+25%	+$8.38M	0.92%	36
2015 Q1	$34.1M	Buy	197,007 +9,183	+5%	+$1.66M	0.74%	39
2014 Q4	$34.8M	Buy	+187,824	New	+$34.8M	0.76%	39
2014 Q3	–	Sell	-241,103	Closed	-$37.7M	–	609
2014 Q2	$37.7M	Sell	241,103 -109,333	-31%	-$17.3M	0.85%	43
2014 Q1	$53.3M	Buy	350,436 +1,800	+0.5%	+$286K	1.15%	30
2013 Q4	$46.3M	Sell	348,636 -109,196	-24%	-$13.1M	1%	35
2013 Q3	$53.2M	Sell	457,832 -49,143	-10%	-$5.39M	1.24%	26
2013 Q2	$46.8M	Buy	+506,975	New	+$48.9M	1.12%	29